Results 1 to 10 of about 2,268 (103)
LOW MOLECULAR WEIGHT HEPARINS [PDF]
Medical Journal Armed Forces India, 1998 Low-molecular-weight heparins (LMWH) are a new group of parenteral anticoagulants. They represent a major clinical advance in anticoagulation since the identification of unfractionated heparin (UFH) in 1922 and the introduction of the synthetic coumarin derivative, warfarin, in 1948.
J N, Huang, A, Shimamura
openaire +4 more sources
Inhibition of trypsin by heparin and dalteparin, a low molecular weight heparin [PDF]
Journal of the Serbian Chemical Society, 2009 The interaction between trypsin, a prototype S1 serine protease, with heparin and its low molecular weight derivative dalteparin were investigated. Direct inhibition of the proteolytic activity of trypsin by heparin and dalteparin, used in concentrations
OLIVERA M. BOSNIĆ +3 more
doaj +3 more sources
American Heart Journal Plus, 2023 Unfractionated heparin (UFH) is commonly used for several life-threatening conditions requiring anticoagulant therapy but failure to reach therapeutic levels in 24 h can be associated with adverse outcomes.
Kayla Torppey +7 more
doaj +1 more source
Low molecular weight heparin in COVID-19: benefits and concerns
Frontiers in Pharmacology, 2023 Since its emergence, the COVID-19 pandemic had a dramatic impact on the public health worldwide and it scarred the medical, economical, and social determinants of health.
Adham Makarem +10 more
doaj +1 more source
Microneedle based transcutaneous delivery of low molecular weight heparin
Pakistan Journal of Pharmaceutical Sciences, 2021 This study aimed to fabricate and characterize polymeric microneedle patches for rapid and non-invasive administration of enoxaparin across skin layers. The patches comprising of PVA, sorbitol and enoxaparin sodium were prepared by employing micromolding
Saman Zafar +7 more
doaj +1 more source
The Effect of Low Molecular Weight Heparins on Placentation: A Rat Model Study
Cumhuriyet Science Journal, 2022 Low molecular weight heparins (LMWHs) have been used for the treatment for recurrent pregnancy loss (RPL) for a long time. We aimed to investigate the efficacy of the LMWHs on angiogenesis and apoptosis during placentation.
Gülizar Özer +3 more
doaj +1 more source
Low molecular weight heparins [PDF]
Intensive and Critical Care Nursing, 1996 A new class of anticoagulant with advantages over standard heparin were introduced in 1990. Collectively termed low molecular weight heparins, their role is increasing in the treatment and prophylaxis of thromboembolism.
openaire +4 more sources
Archives of Medical Science, 2021 Introduction The role of low-dose aspirin combined with low-molecular-weight heparin (LMWH) in the treatment of preeclampsia (PE) remains unclear. We aimed to assess the efficacy and safety of low-dose aspirin combined with LMWH in PE treatment, to ...
Chunfeng Wu +3 more
doaj +1 more source
BMC Musculoskeletal Disorders, 2020 Background Hip fractures have become a severe public health problem, especially in very elderly patients. Most of them are treated with low molecular weight heparin as prophylaxis or treatment of venous thromboembolism.
Yijun Liu +5 more
doaj +1 more source
Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
Clinical and Applied Thrombosis/Hemostasis, 2019 Heparin and its low-molecular-weight heparin derivatives are widely used clinical anticoagulants. These drugs are critical for the practice of medicine in applications, including kidney dialysis, cardiopulmonary bypass, and in the management of venous ...
Jianle Chen BS +13 more
doaj +1 more source